Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05544955 · ClinicalTrials.gov registry record · NA

Protein Ingestion Timing on Body Composition and Biochemical Markers in Resistance-trained Males

A NA study of Physical Performance and Hypertrophy, sponsored by Marymount University.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05544955 is a NA study of Physical Performance and Hypertrophy that has completed, run by Marymount University. The registered enrollment target is 40 participants, below the 3,603-participant average among 6 other Physical Performance trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05544955, a NA study of Physical Performance and Hypertrophy, has completed, sponsored by Marymount University.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Protein ingestion timing is an important component for muscle accretion. The investigators hypothesized that protein ingestion timing could affect muscular adaptations and performance in resistance-trained men.

Interventions

  • DIETARY_SUPPLEMENT isolate whey protein prior to and immediately after resistance training
  • DIETARY_SUPPLEMENT isolate whey protein 3 hours prior to and 3 hours after resistance training

Study Locations (1)

Virginia

  • Marymount University - Arlington

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-09-17
Est. Completion 2022-12-31
Phase NA

Sponsor

Marymount University

6 total trials

What the Registry Record Tells You About NCT05544955

The ClinicalTrials.gov registry entry for NCT05544955 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,603-participant average among 6 other Physical Performance trials with a reported enrollment target (99% lower). The listed sponsor is Marymount University, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Physical Performance appearing as the primary indexed condition, and to 2 interventions - of which isolate whey protein prior to and immediately after resistance training is the first listed.

NCT05544955 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT05544955 about?

NCT05544955 is a clinical study titled "Protein Ingestion Timing on Body Composition and Biochemical Markers in Resistance-trained Males". Protein ingestion timing is an important component for muscle accretion. The investigators hypothesized that protein ingestion timing could affect muscular adaptations and performance in resistance-trained men.

What is the current status of trial NCT05544955?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-09-17. Estimated completion is 2022-12-31.

What conditions does trial NCT05544955 study?

This clinical trial studies the following conditions: Physical Performance, Hypertrophy.

What interventions are being tested in trial NCT05544955?

The interventions under investigation include: isolate whey protein prior to and immediately after resistance training (DIETARY_SUPPLEMENT), isolate whey protein 3 hours prior to and 3 hours after resistance training (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05544955?

This trial is sponsored by Marymount University, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05544955 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Physical Performance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.